Open Orphan Earnings Estimate

Open Orphan Earnings per Share Projection vs Actual

About Open Orphan Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Open Orphan earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Open Orphan estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Open Orphan fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Open Orphan Plc operates as a pharmaceutical service and contract research company. Further, the company provides preclinical and early clinical research services sales and marketing services and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC , and PK and medical writing to a range of European clients. Open Orphan is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Other Information on Investing in Open Pink Sheet

Open Orphan financial ratios help investors to determine whether Open Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Open with respect to the benefits of owning Open Orphan security.